SENSORMATIC-SOLUTIONS
12.2.2020 08:02:09 CET | Business Wire | Press release
Johnson Controls announced today its leading global retail solutions portfolio, Sensormatic Solutions , will showcase its latest product innovations at EuroShop 2020 , 16-20 February 2020 at the Düsseldorf Exhibition Centre in Germany. By combining insights into retail inventory, shopper traffic and loss prevention, Sensormatic Solutions powers operational excellence at scale and helps retailers create unique shopper experiences.
Sensormatic Solutions continues to fast forward retail with its portfolio of smart, connected and scalable solutions. The technologies that will be on display at this year’s show leverage the latest in Artificial Intelligence (AI), Machine Learning (ML), smart sensors, and video analytics, and bring to life the new collaboration with Intel Corporation.
Sensormatic Solutions is now working with Intel to deliver scalable, AI-powered solutions for retailers. At EuroShop, the companies will showcase the Computer Vision Platform, which leverages Intel® OpenVINO™ and the Sensormatic Smart Hub and Artificial Intelligence Camera developed collaboratively with Intel for the edge. The following solutions will be on display:
- Exterior Store Analytics – Gain shopper journey visibility into blind spots in queue analytics and the quick service restaurants (QSR) industry using computer vision object detection and tracking technology. Analytics and insights will cover a shopper’s digital brand touch points while online through in store order fulfillment.
- Unified Commerce – Experience improved visibility into real-time inventory information, the foundation of today’s world of unified commerce. Radio-frequency identification-enabled (RFID) cycle counting, interactive restocking and inventory analytics help retailers know exactly what merchandise is available on the sales floor, stock room and other zones for efficient unified commerce execution and a frictionless shopper experience. TrueVUE Cloud enables buy online, pickup in store (BOPIS) tasks through automatic order notification, picking and fulfillment features that allow customers to shop anywhere, anytime. Sure Zone, the latest innovation from TrueVUE Cloud, provides retailers with consistently high inventory accuracy without the need to shield their stores. This RFID inventory management solution not only produces consistently more accurate cycle counts but generates a greater ROI and faster store deployments.
- AI Data Intelligence – Insights platform complete with computer vision, data, AI and machine learning technology that delivers data-driven prescriptive actions to help improve retailers’ performance. Benefiting from our new technology collaboration with Intel, this solution leverages store-level source data related to shopper traffic, inventory position, and loss prevention, and helps drive targeted behavior to improve store operations.
- AI Vision Intelligence – The AI Vision Intelligence demo will show how to drive targeted behavior to improve store operations and shopper experience. It encompasses deep learning models, image processing and the AI camera developed with Intel to assess associates’ responsiveness to customers and measure how customers interact with merchandise and more.
- Shopper Engagement – The Shopper Engagement demo is intended to help provide actionable insights regarding shopper behaviors along the shopping journey. Combined with the AI camera developed collaboratively with Intel, Sensormatic Solutions technology enables retailers to gain real-time visibility and predictive analytics for accurate decision making. The solution will provide real-time information regarding inventory levels dropping below defined goals, out of stock conditions by SKU, and shoppers’ viewing and interactions with merchandise.
- Dynamic Content Delivery – In partnership with VSBLTY, a leading software technology company, Dynamic Content Delivery will showcase retail solutions that leverage camera and sensor technology with AI to provide real-time analytics and audience measurement. The VSBLTY solution brings the advantage of online advertising into the brick and mortar landscape with systems that integrate signage, security and analytics.
These innovations and more will be showcased at EuroShop 2020 trade show in Düsseldorf, Germany. Visit us in Hall 6, Stand C01 between 16-20 February to see firsthand how inventory, loss prevention and shopper traffic solutions fast forward retail and enable smart, connected shopper engagement.
To experience firsthand how our solutions come into play on a customer level, please visit our special presentation “How ShopperTrak’s data analytics proved commercial success of Designer Outlet Croatia” on Retail Technology Stage on Sunday, 16th February 2020 at 11 a.m. Thomas Hillebrand, General Manager Europe and Global Accounts at ShopperTrak, part of Sensormatic Solutions, will focus on a recent project – Designer Outlet Croatia and IngKa Centres – which reveals how traffic data insights are being used to measure the success of a unique hybrid development - and drive improvements.
About Johnson Controls
At Johnson Controls, we transform the environments where people live, work, learn and play. From optimizing building performance to improving safety and enhancing comfort, we drive the outcomes that matter most. We deliver our promise in industries such as healthcare, education, data centers and manufacturing. With a global team of 105,000 experts in more than 150 countries and over 130 years of innovation, we are the power behind our customers’ mission. Our leading portfolio of building technology and solutions includes some of the most trusted names in the industry, such as Tyco®
, York®
, Metasys®
, Ruskin®
, Titus®
, Frick®
, Penn®
, Sabroe®
, Simplex®
, Ansul®
and Grinnell®
. For more information, visit www.johnsoncontrols.com
or follow us @johnsoncontrols on Twitter.
About Sensormatic Solutions
Sensormatic Solutions is the leading global retail solutions portfolio of Johnson Controls enabling smart and connected shopper engagement. By combining critical insights into retail inventory, shopper traffic and loss prevention, Sensormatic Solutions powers operational excellence at scale and helps create unique shopping experiences. Our solutions deliver real-time visibility and predictive analytics for accurate decision-making across the enterprise, enabling retailers to confidently move into the future. With more than 1.5 million data collection devices in the retail marketplace, we capture 40 billion shopper visits and track and protect billions of items each year. Our retail portfolio features the premier Sensormatic, ShopperTrak and TrueVUE brands. Please visit http://www.sensormatic.com
, or follow us on LinkedIn
, Twitter
, and our YouTube channel
.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200211006075/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom